Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the jetpack-backup domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/vgbdoo6u2d7y/public_html/mcmillanresearch.com/wp-includes/functions.php on line 6121
About Us - McMillan Research Limited
Select Page

COVID-19 Research Project

The aim of this research project is to understand the immune dysregulation in COVID-19 which is the primary cause of lung damage, leading to death, in order to change the course of the pandemic. The hypothesis is that autoimmunity to ACE-2 (the viral entry receptor) is triggered when elevated levels of serum ACE-2 bind to viral spike proteins. Research at Johns Hopkins University recently confirmed a part of this hypothesis by identifying IgM autoantibodies to ACE-2 in the serum of severe cases. This research project is expected to focus on a comprehensive search for autoantibodies to ACE-2 in people with COVID-19.

Dr Philip McMillan

Dr Philip McMillan

Co-Founder & Executive Director

Medical doctor with a unique collaborative approach to medical research, applying the fundamentals of physiology and pathology to understand disease. Focused on COVID-19, long Covid and chronic health conditions such as dementia and arthritis.

Jacqueline Allison, PhD CFA

Jacqueline Allison, PhD CFA

Co-Founder

Investment and communications professional with more than twenty years of corporate and financial markets experience, and a passion for helping others. Director of several early-stage companies across multiple sectors including healthcare.

Disclaimer

McMillan Research does not currently have real world evidence data regarding all aspects of autoimmunity in COVID-19. The theory of autoimmunity in COVID-19 could form the basis for clinical investigation and medical monitoring. There are many challenges associated with clinical trials, especially clinical human trials. A clinical trial study requires a comprehensive development plan, and may use clinical biostatistics. A centre for clinical research focused on long COVID, could potentially provide much needed solutions.